Global Gene Synthesis Market Expected to Reach USD 7.98 Billion by 2030, Growing at a CAGR of 19.14%
Straits Research has unveiled its latest insights on the global gene synthesis market. In 2021, the market size was valued at USD 1.65 billion and is projected to grow exponentially, reaching USD 7.98 billion by 2030. This impressive growth trajectory reflects a compound annual growth rate (CAGR) of 19.14% during the forecast period (2022–2030).
Market Definition Gene synthesis refers to the artificial construction of gene sequences, allowing researchers to design, optimize, and synthesize genes for various applications, including research, therapeutic development, and diagnostics. This technology has revolutionized biotechnology by enabling precise manipulation of genetic information without relying on natural templates.
Latest Market Trends
Adoption of AI and Automation in Gene Synthesis: Artificial intelligence and robotic systems are being employed to streamline synthesis workflows, increasing precision and efficiency.
Expanding Applications in Personalized Medicine: Gene synthesis is playing a critical role in developing personalized therapeutics, particularly in cancer and rare genetic disorders.
Growing Investments in Synthetic Biology: Governments and private investors worldwide are funding synthetic biology initiatives, fostering innovation and expanding market reach.
Get a Full PDF Sample Copy of the Report
Growth Factors
Rising Demand for Biologics and Gene Therapies: Increased adoption of biologics and gene therapies in healthcare drives the demand for synthetic genes.
Advancements in CRISPR and Gene Editing Technologies: Innovations in gene editing tools have created new opportunities for precise and efficient gene synthesis.
Increased Funding for Genomics Research: Governments and private organizations are heavily investing in genomics research, fueling the demand for advanced gene synthesis technologies.
Key Market Opportunities
Development of Advanced Synthetic Biology Tools: Innovations in synthetic biology offer significant potential for expanding gene synthesis capabilities.
Rising Demand in Emerging Markets: Rapid industrialization and increasing investments in Asia-Pacific and Latin America present lucrative opportunities.
Collaborations Between Academic Institutions and Biotech Firms: Partnerships foster innovation, accelerating the adoption of gene synthesis technologies across various sectors.
Market Segmentation By Method
Solid-phase Synthesis
Chip-based Synthesis
PCR-based Enzyme Synthesis
By Service
Antibody DNA Synthesis
Viral DNA Synthesis
Others
By Application
Gene and Cell Therapy Development
Vaccine Development
Disease Diagnosis
Others
By End-User
Biotechnology and Pharmaceutical Companies
Academic and Government Research Institutes
Contract Research Organizations
Regional Insights The global gene synthesis market is currently dominated by North America, owing to its advanced healthcare infrastructure, strong R&D ecosystem, and significant investment in biotechnology. Meanwhile, the Asia Pacific region is expected to exhibit the fastest growth during the forecast period, driven by increased funding, a growing focus on precision medicine, and expanding biopharmaceutical manufacturing capabilities.
Key Market Players
GenScript
Brooks Automation, Inc. (GENEWIZ)
Boster Biological Technology
Twist Bioscience
ProteoGenix
Biomatik
ProMab Biotechnologies, Inc.
Thermo Fisher Scientific, Inc.
Integrated DNA Technologies, Inc.
OriGene Technologies, Inc.
For More Information or Query or Customization Before Buying, Visit https://straitsresearch.com/buy-now/gene-synthesis-market
Straits Research’s report provides a detailed analysis of the market dynamics, including drivers, restraints, opportunities, and challenges. The comprehensive study also highlights strategic developments by key players, helping stakeholders make informed decisions.
